High Purity Ledipasvir API Powder 1256388-51-8
Quick Details Port: Beijing/Shandong/Tianjing Payment Terms: L/C,D/A,D/P,T/T,Western Union,MoneyGram,Trade Assurance Supply Ability: 500 Kilometer/Kilometers per Month Usage: Animal Pharmaceuticals CAS No: 1256388-51-8 Grade Standard: Medicine Grade, Pharma Grade Product Name: Ledipasvir Purity: 99%min Shelf life: 2 Years Dosage Form: capsule,Powder Appearance: White Powder Function: Anti HCV Type: Antibiotic and Antimicrobial Agents MF: C 49H54F2N8O6 Animal Type: Aquatic Animals,cattle,fowl,Horse,Other Special Breeding Animals,PETS,PIG,SHEEP Application: Pharmaceutical Raw Intermediates Packaging Detail: 25kgs packaging Fiber drum outside and plastic bag inside 1-25kgs packaging aluminium bag outside and double plastic bag inside Or as per require Product Name: Ledipasvir MF: C49H54F2N8O6 CAS No.: 1256388-51-8 Purity: 99% Specification: 99% Origin: China Ledipasvir is a direct acting antiviral (DAA) medication used as part of combination therapy to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV). After completing Phase III clinical trials, on February 10, 2014 Gilead filed for U.S. approval of a ledipasvir/sofosbuvir fixed-dose combination tablet for genotype 1 hepatitis C.The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication and can be used to treat patients with genotypes 1a or 1b without PEG-interferon or ribavirin. Ledipasvir is an orally available inhibitor of the […]